Pemetrexed with platinum combination as a backbone for targeted therapy in non–small-cell lung cancer
TE Stinchcombe, H Borghaei, SS Barker, JA Treat… - Clinical Lung Cancer, 2016 - Elsevier
Standard platinum-based chemotherapy combinations for advanced non–small-cell lung
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
[引用][C] Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer
TE Stinchcombe, H Borghaei, SS Barker, JA Treat… - Clinical Lung …, 2016 - cir.nii.ac.jp
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell
Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer
TE Stinchcombe, H Borghaei, SS Barker, JA Treat… - Clinical Lung …, 2016 - infona.pl
Standard platinum-based chemotherapy combinations for advanced non–small-cell lung
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer
TE Stinchcombe, H Borghaei, SS Barker… - Clinical Lung …, 2016 - clinical-lung-cancer.com
Standard platinum-based chemotherapy combinations for advanced non–small-cell lung
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
Best Lung Cancer Research of 2014
TE Stinchcombe - Oncology Times, 2015 - journals.lww.com
JCO. 2014.58. 2635), updates a 1997 policy statement on the same topic. The new
statement was drafted by a team of authors led by Jeffrey S. Weber, MD, PhD, Senior …
statement was drafted by a team of authors led by Jeffrey S. Weber, MD, PhD, Senior …
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer
TE Stinchcombe, H Borghaei, SS Barker… - Clinical lung …, 2016 - pubmed.ncbi.nlm.nih.gov
Standard platinum-based chemotherapy combinations for advanced non-small-cell lung
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
TE Stinchcombe, H Borghaei, SS Barker… - Clinical Lung …, 2015 - europepmc.org
Standard platinum-based chemotherapy combinations for advanced non-small-cell lung
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …
cancer (NSCLC) have reached a plateau in terms of the survival benefit they offer for …